Judge In Taxotere Lawsuits Orders Settlement Conference Ahead Of First Bellwether Trial

   

Taxotere Lawsuits Allege Women Undergoing Chemotherapy For Breast Cancer Suffered Permanent Hair Loss After Receiving The Chemo Drug

Taxotere Lawsuits taxotere lawsuit taxotere hair-loss-lawsuit side effects hair lossTaxotere lawsuits move forward as the first bellwether trial is scheduled for September 2018, but before the trial, the judge has ordered both sides to participate in a settlement conference for the chemo therapy drug litigation. There have been 1,270 Taxotere lawsuits filed on behalf of women who have allegedly suffered permanent hair loss after receiving Taxotere to treat breast cancer. The complaints contend that Taxotere’s developer Sanofi-Aventis and its subsidiaries mislead women about the drug’s safety and failed to adequately warn that women would permanently lose their hair after taking Taxotere. (In Re: Taxotere (Docetaxel) Products Liability Litigation – Taxotere Lawsuits – MDL 2740)

“We are pleased to see that a jury will hear the devastating stories of women who say they suffered life-threatening breast cancer only to permanently lose their hair during treatment for the disease,” says Dr. François Blaudeau, founder of Southern Med Law, who is also a practicing attorney and an obstetrician/gynecologist.

Southern Med Law represents women in drug side-effect lawsuits such as Taxotere hair loss complaints and in cases involving defective medical devices that cause serious injuries. If you have suffered permanent hair loss or other side effects after receiving breast cancer treatment involving the Taxotere chemotherapy, you can arrange for a free, no-obligation legal evaluation by calling Southern Med Law today at 205-547-5525 or visit www.southernmedlaw.com for more information and news on upcoming meetings and filings.

In a Case Management Order (CMO) issued July 21, U.S. District Judge Kurt D. Engelhardt ordered the parties to attend a settlement conference with a magistrate judge on June 29, 2018. Judge Engelhardt is presiding over the Taxotere multidistrict litigation in the Eastern District of Louisiana. The CMO also requires the parties to submit a Joint Confidential Status Report by July 6, 2018, if a resolution has not been reached by that date. The parties have already selected 10 potential cases for bellwether trials and the first trial is expected to begin on September 24, 2018. Bellwether trials are seen as “test trials” that help plaintiffs, defendants and the court determine the outcome of future trials. Depending on the outcomes, the parties may consider settling other lawsuits pending in the litigation. (In Re: Taxotere (Docetaxel) Products Liability Litigation – Taxotere Lawsuits – MDL 2740)

Taxotere (docetaxel) was approved by the U.S. Food and Drug Administration in 1996 to treat locally advanced or metastatic breast cancer in women whose previous chemotherapy treatments failed. Taxotere was later approved to treat prostate cancer, stomach cancer and head and neck cancer. Taxotere is part of a family of drugs known as Taxanes which block cell growth by interfering with cell division. Taxanes are widely used as chemotherapy agents. In addition to hair loss, patients taking Taxotere reported other side effects that include gastrointestinal bleeding, infections, nausea and vomiting, anemia, and skin reactions.
[accessdata.fda.gov/drugsatfda_docs/label/2010/020449s059lbl.pdf]

According to the Taxotere complaints, hair loss is a common side effect of chemotherapy treatments. However, plaintiffs contend that Sanofi-Aventis did not warn doctors and their patients that hair loss would be permanent after taking a Taxotere chemotherapy treatment. One lawsuit recently added to the Taxotere litigation was filed on behalf of a Florida woman who underwent cancer treatment with Taxotere in November 2007 and continued to February 2008. The woman claimed that her hair never grew back after she stopped the treatment. (Taxotere Lawsuit No. 2:17-cv-06757, In Re: Taxotere (Docetaxel) Products Liability Litigation – Taxotere Lawsuits – MDL 2740)

About Southern Med Law And Filing A Taxotere Hair Loss Lawsuit

Led by Dr. François Blaudeau, an attorney and a practicing obstetrician/ gynecologist, the legal staff at Southern Med Law possesses a deep understanding of the complex medical and legal questions at issue in Taxotere Hair Loss Lawsuits. They are not afraid to take on the nation’s largest corporations in their pursuit of justice, and are committed to ensuring that all victims have access to the type of aggressive legal advocacy that assures success. To speak to one of the firm’s Taxotere Hair Loss lawsuit attorneys for a FREE Taxotere Hair Loss Lawsuit consultation please call 205-547-5525 or fill out the online form.

Southern Med Law
François M. Blaudeau, MD JD FACHE FCLM Esquire
2224 1st Avenue North
Birmingham, Alabama 35203
Phone: (205) 547-5525
Fax: (205) 547-5526
francois@southernmedlaw.com
www.southernmedlaw.com
Medical Negligence/MedicalDevice/Pharma/Qui Tam

This entry was posted in Southern Med Law | Article. Bookmark the permalink.